for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Shanghai Pharmaceuticals Holding H Shs

2607.HK

Latest Trade

14.86HKD

Change

-0.08(-0.54%)

Volume

3,432,200

Today's Range

14.80

 - 

14.96

52 Week Range

13.04

 - 

19.88

As of on the Hong Kong Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
14.94
Open
14.86
Volume
3,432,200
3M AVG Volume
61.46
Today's High
14.96
Today's Low
14.80
52 Week High
19.88
52 Week Low
13.04
Shares Out (MIL)
2,842.09
Market Cap (MIL)
54,426.53
Forward P/E
8.72
Dividend (Yield %)
--

Latest Developments

更多

Shanghai Pharmaceuticals Holding Received Reply From CSRC

Shanghai Pharma's Unit To Set Up JV With BIOCAD Holding Hong Kong

Shanghai Pharmaceuticals' H1 Net Profit Up 12.6% Y/Y

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Shanghai Pharmaceuticals Holding H Shs

Shanghai Pharmaceuticals Holding Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceuticals. The Company's businesses include the research and registration, production, sales, distribution and retailing of pharmaceutical products, among others. Its products are applied in cardiovascular system, anti-cancer and immunoregulation, anti-infection and metabolism, as well as other fields. The Company operates businesses in domestic and overseas markets.

Industry

Major Drugs

Contact Info

Shanghai Pharmaceutical Mansion

No.200 Taicang Road

+86.21.63730908

http://www.sphchina.com/

Executive Leadership

Jun Zhou

Chairman of the Board, Non-Executive Director

Min Zuo

President, Executive Director

Bo Shen

Chief Financial Officer, Vice President, Executive Director

Yongzhong Li

Vice President, Executive Director

Dawei Liu

Vice President, Secretary of the Board

Key Stats

1.93 mean rating - 14 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2016

120.8K

2017

130.8K

2018

159.1K

2019(E)

184.4K
EPS (CNY)

2016

1.190

2017

1.310

2018

1.370

2019(E)

1.524
Price To Earnings (TTM)
9.26
Price To Sales (TTM)
0.28
Price To Book (MRQ)
0.95
Price To Cash Flow (TTM)
7.73
Total Debt To Equity (MRQ)
80.26
LT Debt To Equity (MRQ)
25.31
Return on Investment (TTM)
10.23
Return on Equity (TTM)
3.76

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up